Exelixis | Creditori Commerciali





Creditori Commerciali Cambiamento Data
Acadia Pharmaceuticals USD 21.75M 1.65M 2025-09
Agios Pharmaceuticals USD 18.36M 1.2M 2025-12
Akebia Therapeutics USD 10.09M 1.47M 2025-09
Amgen USD 20.89B 1.25B 2025-12
AstraZeneca USD 25.28B 252M 2025-12
Bayer EUR 6.38B 343M 2025-09
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Cytokinetics USD 22.08M 46.46M 2025-09
Eisai JPY 85.49B 4.76B 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Esperion Therapeutics USD 77.51M 2.81M 2025-09
Exelixis USD 29.62M 4.27M 2025-12
Genmab DKK 6M 2M 2025-09
Glaxosmithkline GBP 21.07B 7.42B 2025-09
Incyte USD 1.63B 1.46B 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
MacroGenics USD 5.94M 1.28M 2025-09
Merck USD 4.15B 102M 2025-09
Moderna USD 317M 50M 2025-12
Nektar Therapeutics USD 15.56M 1.28M 2025-09
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Novartis USD 4.56B 49M 2025-09
Pfizer USD 5.02B 142M 2025-09
Puma Biotechnology USD 6.39M 962K 2025-09
Sanofi EUR 22.93B 2.89B 2025-12
Takeda JPY 467.59B 28.61B 2025-12
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Xencor USD 9.08M 9.45M 2025-09


Exelixis Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.